“Data and artificial intelligence are opening up tremendous prospects for drug discovery, disease prevention and improved treatment adherence across the entire pharmaceutical value chain,” Virginie Dominguez, executive vice president of digital, data and information systems at Servier, said in the news release.
She said the company chose Google Cloud because of its knowledge of the healthcare sector, commitment to regulatory compliance and “stringent digital sovereignty requirements.”
Google Cloud is working with health systems such as Brentwood, Tenn.-based LifePoint Health and New Hyde Park, N.Y.-based Northwell Health on similar efforts in the hospital sphere.
Servier said the collaboration could help fast-track drug development through AI or use real-world data to do advanced analyses of drug efficacy and tolerability.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
